Nov. 13, 2018 Price forecast | 2 weeks: 0.40% | 1 month: 0.61% | 3 months: 0.67%

BDX stock forecast

Our latest prediction for Becton, Dickinson & Co.'s stock price was made on the Nov. 13, 2018 when the stock price was at 234.50$.

In the short term (2weeks), BDX's stock price should outperform the market by 0.40%. During that period the price should oscillate between -2.95% and +3.83%.

In the medium term (3months), BDX's stock price should outperform the market by 0.67%. During that period the price should oscillate between -6.53% and +9.26%.

About Becton, Dickinson & Co.

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

At the moment the company generates 17290M USD in revenues.

On its last earning announcement, the company reported a profit of 3.94$ per share.

The book value per share is 79.81$

Becton, Dickinson & Co. website

Three months stock forecastNov. 13, 2018


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
17290M 47.90% 2238M 12.90% 1233M 3.94 3.08 118.70% 275M 79.81 3328M -957M 2371M